Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
RECURSION PHARMACEUTICALS, INC. | Chief R&D Commercial Officer, Director | Class A Common Stock | 497K | $4.04M | $8.13 | Aug 1, 2024 | Direct |
RECURSION PHARMACEUTICALS, INC. | Chief R&D Commercial Officer, Director | Stock Option (Right to Buy) | 994K | Aug 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RXRX | RECURSION PHARMACEUTICALS, INC. | Aug 1, 2024 | 2 | $0 | 4 | Aug 5, 2024 | Chief R&D Commercial Officer, Director |
RXRX | RECURSION PHARMACEUTICALS, INC. | Apr 16, 2024 | 0 | $0 | 3 | Apr 25, 2024 | Director |